IMVT compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

IMVTImmunovant, Inc.

TNGXTango Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

IMVTwithTNGX

×0.51co-movement · TNGX on IMVT · 500d

r 0.27scale to r 0.75

Shared co-movers4with IMVTwith TNGX

IDYAIDEAYA Biosciences, Inc.r 0.49r 0.33

CLDXCelldex Therapeutics, Inc.r 0.44r 0.30

KURAKura Oncology, Inc.r 0.46r 0.28

NRIXNurix Therapeutics, Inc.r 0.47r 0.28

IMVT, solidTNGX, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

IMVTImmunovant, Inc.

29.14▼−1.68%· post 29.57

Mkt cap$6.0BRevenue—Revenue—

TNGXTango Therapeutics, Inc.

22.72▲+0.84%· post 22.72

ClosedOct 30 '26

Mkt cap$3.8BRevenue$54MQ3 FY25Revenue$42MFY24

Compare

ClosedOct 30 '26

IMVTImmunovant, Inc.

TNGXTango Therapeutics, Inc.

29.14▼−1.68%post 29.57

Price

22.72▲+0.84%post 22.72

$6.0B

Mkt cap

$3.8B

—

Revenue

$54MQ3 FY25

—

Revenue

$42MFY24

IMVT29.14▼−1.68%vsTNGX22.72▲+0.84%ClosedOct 30 '26